SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001005150-03-000852
Filing Date
2003-04-30
Accepted
2003-04-30 17:00:59
Documents
1
Period of Report
2003-06-18
Effectiveness Date
2003-04-30

Document Format Files

Seq Description Document Type Size
1 def14a.txt DEF 14A 70486
  Complete submission text file 0001005150-03-000852.txt   72122
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-15070 | Film No.: 03673747
SIC: 2834 Pharmaceutical Preparations